Improved outcomes from quadruplet KCRD induction in newly diagnosed myeloma patients
Improved outcomes from quadruplet KCRD induction in newly diagnosed myeloma patients
Once-weekly carfilzomib combined with lenalidomide and dexamethasone for multiple myeloma
What is the role of autologous stem cell transplant in multiple myeloma?
First results of the GMMG-CONCEPT trial for multiple myeloma
Iberdomide in combination with dexamethasone for multiple myeloma
PLEIADES: Daratumumab combinations for multiple myeloma
Treatment options for high risk relapsed/refractory multiple myeloma
Ruxolitinib, lenalidomide and methylprednisolone for relapsed/refractory multiple myeloma
BCMA: A new biomarker for multiple myeloma
Continuous treatment versus fixed duration therapy: Using real-world evidence to guide treatment paradigms for multiple myeloma
Appraising an NTRK testing algorithm: When, what, how
Oncogenomics: From a surgical perspective